A new study initiated this month by five leading research funders and institutions will estimate the health and economic benefits of UK investment in medical research into musculoskeletal conditions.
Supported by Arthritis Research UK, The Wellcome Trust, the Medical Research Council, the Department of Health and the Academy of Medical Sciences, this is the third in a series of health economic studies which have focused on the return on public and charitable investment in medical research.
Following previous studies on cardiovascular disease and cancer research, which demonstrated that medical research investment generates significant health and economic gains over the long term, the new study will focus on research into musculoskeletal conditions, including inflammatory forms of arthritis, conditions of musculoskeletal pain such as osteoarthritis, and osteoporosis.
